Injectable PD-1 inhibitor monoclonal antibody used in oncology immunotherapy protocols. Procured by hospitals, cancer treatment centers, and pharmaceutical wholesalers for intravenous administration in managing solid tumors including melanoma, non-small cell lung cancer, and renal cell carcinoma.